Saba Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-131,005
| Closed | -$1.85M | – | 394 |
|
|
2024
Q1 | $1.85M | Sell |
131,005
-48,658
| -27% | -$687K | 0.03% | 136 |
|
|
2023
Q4 | $1.88M | Sell |
179,663
-9,340
| -5% | -$97.5K | 0.04% | 171 |
|
|
2023
Q3 | $1.93M | Sell |
189,003
-63,835
| -25% | -$651K | 0.05% | 182 |
|
|
2023
Q2 | $1.9M | Buy |
252,838
+42,360
| +20% | +$319K | 0.05% | 206 |
|
|
2023
Q1 | $1.86M | Buy |
210,478
+174,230
| +481% | +$1.54M | 0.04% | 316 |
|
|
2022
Q4 | $331K | Buy |
+36,248
| New | +$331K | ﹤0.01% | 532 |
|
|
2021
Q4 | – | Hold |
0
| – | – | – | 748 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 525 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 450 |
|
|
2019
Q4 | – | Sell |
-40,187
| Closed | -$276K | – | 88 |
|
|
2019
Q3 | $276K | Buy |
+40,187
| New | +$276K | 0.01% | 73 |
|